A best evidence topic was constructed according to a structured protocol. The question addressed was 'Does perioperative furosemide usage reduce the need for renal replacement therapy in cardiac surgery patients?' Forty-seven papers were found using the reported search, of which 10 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Current best available evidence to resolve the issue includes a systematic review and nine randomized controlled trials (RCTs). The systematic review of seven RCTs and one observational study has demonstrated that in patients who have undergone cardiac surgery, a more consistent and sustained diuresis is produced by a continuous infusion of furosemide compared with intermittent bolus doses of furosemide. However, there does not appear to be a significant difference in the total urine output or a change in serum electrolyte levels when furosemide is administered as a continuous infusion compared with intermittent bolus doses. Three RCTs recruiting neonatal and paediatric patients after open heart surgery also validated the safety and efficacy of furosemide infusion as well as intermittent bolus doses. Two of the five RCTS in adult cardiac surgery patients showed that furosemide infusion was associated with a reduced need for renal replacement therapy (RRT), while two RCTs failed to show any benefit and one reported an increased incidence of renal impairment. We conclude that continuous furosemide infusion in the perioperative period promotes a gentle and sustained diuresis in cardiac surgery patients. The evidence supporting the benefit of this strategy in terms of reducing the need for RRT is weak. At the same time, current best available evidence, albeit from small RCTs, suggests that the timely introduction of continuous furosemide infusion does not increase the incidence of renal impairment after cardiac surgery.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This protocol is fully described in the ICVTS [1] .
CLINICAL SCENARIO
Your consultant is about to operate on a 65-year old elective patient with left main stem disease, eGFR 50 ml/min and concomitant longstanding hypertension and diabetes. The anaesthetist suggests starting furosemide infusion perioperatively to diurese the patient and to reduce the risk of acute kidney injury and subsequent renal replacement therapy (RRT). You are not aware of any convincing papers supporting this strategy and decide to look up the evidence yourself. 
THREE-PART QUESTION

SEARCH STRATEGY
The English language scientific literature was reviewed primarily by searching Medline from 1950 through December 2011 using Ovid Interface. This was expanded through PubMed.
[ The 'related articles' function was used to expand the search and all abstracts, studies and citations scanned were reviewed. The reference lists of those articles viewed were also scanned for relevant articles. [8, 10, 11] . All nine individual studies were randomized controlled trials (RCTs) ( Table 1) .
COMMENT
Gulbis and Spencer [2] published a systematic review of eight studies, including seven RCTs and one observational study, and concluded that a more consistent and sustained diuresis is produced by a continuous infusion of furosemide compared with intermittent bolus doses of furosemide. However, there does not appear to be a significant difference in the total urine output or a change in serum electrolyte levels when furosemide is administered as a continuous infusion compared with intermittent bolus doses. Four of the eight studies reported no adverse effects on kidney function. Furthermore, Eighteen patients undergoing open cardiac surgery. Subjects were randomized to receive furosemide either as 2 bolus injections (n = 9) or continuous infusion (n = 9). Protocol was started on the first postoperative day and continued for 12 h the systematic review concluded that the infusion duration should not exceed 72 h. Lassnigg et al. [3] , in an RCT, evaluated the effectiveness of dopamine or furosemide in the prevention of renal impairment after cardiac surgery. A total of 126 patients with preoperatively normal renal function undergoing elective cardiac surgery received a continuous infusion of either 'renal-dose' dopamine (2 µg/kg per min) (group D), furosemide (0.5 µg/kg per min) (group F) or isotonic sodium chloride as a placebo (group P), starting at the beginning of surgery and continuing for 48 h or until discharge from the intensive care unit, whichever came first. It was shown that a continuous infusion of dopamine for renal protection was ineffective and was not superior to a placebo in preventing postoperative dysfunction after cardiac surgery. In contrast, a continuous infusion of furosemide was associated with the highest rate of renal impairment.
Mahesh et al. [4] , in their RCT, did not demonstrate any benefit of a furosemide infusion postoperatively in high-risk cardiac surgery patients. Although the urinary output increased with furosemide, there was no decrease in the renal injury, and no decrease in the incidence of renal dysfunction.
On the contrary, Kunt et al. [5] , in their RCT, showed that a continuous infusion of furosemide seems to be effective in promoting diuresis and decreasing the need for RRT.
Sirivella et al. [6] , in their RCT, randomized 100 patients with postoperative oliguric or anuric renal failure despite adequate postoperative cardiac output and haemodynamic function. Forty patients (group A) were given intermittent doses of diuretics (furosemide, bumetadine and ethracrynic acid) and fluids. Sixty patients (group B) were given a continuous infusion of the solution of mannitol, furosemide and dopamine; the infusion was started within 6 h (mean 3.5 h) in subgroup B1 (n = 30), and later than 6 h (mean 7.5 h) in subgroup B2 (n = 30) after the onset of renal failure. The infusion of solution of mannitol, furosemide and dopamine promoted diuresis in patients with acute postoperative renal failure with adequate postoperative cardiac output and decreased the need for dialysis in the majority of patients. The early administration of this solution in acute renal failure caused the early restoration of renal function to normal or baseline status.
Lim et al. [7] , in their small RCT, showed that routine diuretics promoted an earlier diuresis, but no clinical benefits are apparent in low-risk patients with a normal renal function.
Copeland et al. [9] , in their RCT, showed that a continuous furosemide infusion resulted in a gentle and sustained diuresis.
The three RCTs recruiting paediatric cases after open heart surgery [8, 10, 11] demonstrated that commonly used doses of both intermittent and continuous intravenous furosemide infusion can be safely administered to critically ill neonates and infants as early as 6 h after operation. Furthermore, continuous infusion yields an almost comparable urinary output with a much lower dose of furosemide, and intermittent administration is associated with greater fluctuations in urinary output and a greater need for fluid replacement therapy.
CONCLUSION
Continuous furosemide infusion in the perioperative period promotes a gentle and sustained diuresis in cardiac surgery patients. The evidence supporting the benefit of this strategy in terms of reducing the need for RRT is weak. At the same time, current best available evidence, albeit from small RCTs, suggests that the timely introduction of continuous furosemide infusion does not increase the incidence of renal impairment after cardiac surgery.
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